PDL BioPharma, Inc. (PDL) today announced that the company has received $30.3 million, in addition to previously received revenue interest payments, to conclude PDL’s revenue interest agreement with AxoGen, Inc.

Original post:
PDL BioPharma receives $30.3M to conclude revenue interest contract with AxoGen